Surgery for pulmonary metastases. The Heidelberg experience.
The surgical treatment of pulmonary metastases is now an established technique in the interdisciplinary concept of oncologic therapy. The authors' finding of a 5-year actuarial survival rate of 33% corresponds with the international standard. Unfortunately, data are only rarely provided as to whether the operations were curative or noncurative. The 5-year actuarial survival rate in 76% of the patients with potentially curative macroscopically radical operations was 38% for all organ tumors. For the time being, a series of prognostic factors should be considered in establishing the indication for surgery, and this should help to reduce the risk of undertreatment or overtreatment.
Vogt-Moykopf
I
I
Surgical Department, Hospital for Thoracic Diseases, Heidelberg, Germany.
Krysa
S
S
Bülzebruck
H
H
Schirren
J
J
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D008297:Male; D009017:Morbidity; D011182:Postoperative Care; D011183:Postoperative Complications / Q000453:epidemiology / Q000601:surgery; D011300:Preoperative Care; D011379:Prognosis; D012074:Remission Induction; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D013908:Thoracotomy